Glycyl-L-isoleucine(CAS: 19461-38-2)

Glycyl-L-isoleucine (CAS: 19461-38-2) is subject to the Globally Harmonized System (GHS) for classification and labeling of chemicals, which includes health, environmental, and physical hazards. It is also regulated under REACH in the European Union, where manufacturers and importers must register the substance with the European Chemicals Agency (ECHA). FDA and EPA regulations in the United States may apply based on its intended use, such as in pharmaceuticals or food additives.

Alternative amino acids, such as glycyl-L-leucine or other dipeptides, can be used as synthetic alternatives to Glycyl-L-isoleucine (CAS: 19461-38-2). These alternatives may offer similar biological activities or can be used in specific applications where Glycyl-L-isoleucine is not suitable, depending on the desired properties and end use.

The market for Glycyl-L-isoleucine (CAS: 19461-38-2) is growing due to its importance in pharmaceutical and biotechnological research, particularly in protein engineering and peptide synthesis. Research trends are focusing on its use in drug discovery and development, as well as in the preparation of enzymes and other biologically active peptides. Market dynamics suggest increasing demand as more applications are discovered.

Waste containing Glycyl-L-isoleucine (CAS: 19461-38-2) should be collected in appropriate containers and disposed of through professional waste disposal services to ensure compliance with environmental regulations. Incineration or other environmentally safe disposal methods should be employed, and all handling procedures should follow local, national, and international guidelines for hazardous waste management to minimize environmental impact.